Inhibrx Accounts Payable from 2010 to 2025

INBX Stock  USD 13.49  0.05  0.37%   
Inhibrx Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable will likely drop to about 6.8 M in 2025. Accounts Payable is the amount Inhibrx owes to suppliers or vendors for products or services received but not yet paid for. It represents Inhibrx's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2019-03-31
Previous Quarter
13 M
Current Value
12.4 M
Quarterly Volatility
3.6 M
 
Covid
Check Inhibrx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inhibrx's main balance sheet or income statement drivers, such as Interest Expense of 38.4 M, Minority Interest of 0.0 or Tax Provision of 2.6 K, as well as many indicators such as Price To Sales Ratio of 940, Dividend Yield of 0.0021 or PTB Ratio of 38.9. Inhibrx financial statements analysis is a perfect complement when working with Inhibrx Valuation or Volatility modules.
  
Check out the analysis of Inhibrx Correlation against competitors.
For more information on how to buy Inhibrx Stock please use our How to Invest in Inhibrx guide.

Latest Inhibrx's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Inhibrx over the last few years. An accounting item on the balance sheet that represents Inhibrx obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Inhibrx are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Inhibrx's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inhibrx's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Inhibrx Accounts Payable Regression Statistics

Arithmetic Mean4,200,945
Geometric Mean1,241,283
Coefficient Of Variation108.53
Mean Deviation4,093,688
Median3,115,000
Standard Deviation4,559,251
Sample Variance20.8T
Range13.3M
R-Value0.81
Mean Square Error7.6T
R-Squared0.66
Significance0.0001
Slope778,052
Total Sum of Squares311.8T

Inhibrx Accounts Payable History

20256.8 M
20249.6 M
20238.3 M
20228.3 M
20219.1 M
202013.5 M
20193.1 M

About Inhibrx Financial Statements

Inhibrx investors use historical fundamental indicators, such as Inhibrx's Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Inhibrx. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable9.6 M6.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Inhibrx Stock Analysis

When running Inhibrx's price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.